English, Article edition: Cost Effectiveness of Nasal Budesonide versus Surgical Treatment for Nasal Polyps Fredrik Berggren; Leif Johansson

User activity

Share to:
 
Bookmark: http://trove.nla.gov.au/version/118828
Physical Description
  • article
Language
  • English

Edition details

Title
  • Cost Effectiveness of Nasal Budesonide versus Surgical Treatment for Nasal Polyps
Author
  • Fredrik Berggren
  • Leif Johansson
Physical Description
  • article
Notes
  • Objective: To conduct a cost-effectiveness study of nasal budesonide versus surgical treatment in the management of nasal polyps. Design and methods: A decision-tree model reflecting two different treatment strategies for nasal polyps in Sweden was developed. The first strategy was initial polypectomy, performed under three different sets of circumstances: inpatient functional endoscopic surgery, outpatient evulsion with sedation, or outpatient evulsion with local anaesthesia; all treatments were followed by intranasal treatment with budesonide (Rhinocort(R)) 128mug twice daily. The second strategy was initial intranasal treatment with budesonide 128mug twice daily. Perspective: Healthcare provider perspective. Outcome measures and results: After 1 month, treatment with nasal budesonide was classified as a success (82.5%) or a failure (17.5%) based on clinical study data. In cases of success, the treatment was continued, and in cases of failure, polypectomy was undertaken, followed by budesonide 128mug twice daily. Treatments were evaluated after 4 months using prices from the Central Hospital in Skovde, Sweden. The expected reduction in cost from using initial nasal budesonide treatment compared with the different alternatives of polypectomy were 9760 Swedish kronors (SEK) for inpatient functional endoscopic surgery, SEK2747 for outpatient evulsion with sedation, and SEK672 for outpatient evulsion with anaesthesia (1998 values). Nasal budesonide 128mug twice daily treatment for nasal polyps revealed a potential reduction in costs of 53% compared with the primary surgery approach. Conclusion: Initial treatment of nasal polyps with nasal budesonide provides lower costs than treatment with initial polypectomy with maintained effectiveness.
  • Anti inflammatories, Budesonide, Cost effectiveness, Nasal polyps, Pharmacoeconomics, Surgery
  • RePEc:wkh:phecon:v:21:y:2003:i:5:p:351-356
Language
  • English
Contributed by
OAIster

Get this edition

  • Set up My libraries

    How do I set up "My libraries"?

    In order to set up a list of libraries that you have access to, you must first login or sign up. Then set up a personal list of libraries from your profile page by clicking on your user name at the top right of any screen.

  • All (1)
  • Unknown (1)
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.

User activity


e.g. test cricket, Perth (WA), "Parkes, Henry"

Separate different tags with a comma. To include a comma in your tag, surround the tag with double quotes.

Be the first to add a tag for this edition

Be the first to add this to a list

Comments and reviews

What are comments? Add a comment

No user comments or reviews for this version

Add a comment